Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE.

MLA

Vendrely, Véronique, et al. “Treatment, Outcome, and Prognostic Factors in Non-Metastatic Anal Cancer: The French Nationwide Cohort Study FFCD-ANABASE.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, vol. 183, June 2023, p. 109542. EBSCOhost, https://doi.org/10.1016/j.radonc.2023.109542.

APA

Vendrely, V., Lemanski, C., Pommier, P., LE Malicot, K., Saint, A., Rivin Del Campo, E., Regnault, P., Baba-Hamed, N., Ronchin, P., Crehange, G., Tougeron, D., Menager-Tabourel, E., Diaz, O., Hummelsberger, M., Minsat, M., Drouet, F., Larrouy, A., Peiffert, D., Lievre, A., … Quero, L. (2023). Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 183, 109542. https://doi.org/10.1016/j.radonc.2023.109542

Chicago

Vendrely, Véronique, Claire Lemanski, Pascal Pommier, Karine LE Malicot, Angélique Saint, Eleonor Rivin Del Campo, Pauline Regnault, et al. 2023. “Treatment, Outcome, and Prognostic Factors in Non-Metastatic Anal Cancer: The French Nationwide Cohort Study FFCD-ANABASE.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 183 (June): 109542. doi:10.1016/j.radonc.2023.109542.